- Market Share Growth: Elevated market share from 3.63% in 2023 to over 21% in the first 8 months of 2024. The market share continues to grow, demonstrating ongoing success and increased product adoption.- Volume Growth: Increased volume 577.71% from 127 prescriptions in 2023 to 861 prescriptions in the first 8 months of 2024.- Prescriber Growth: Increased writer count 480% from 35 in 2023 to 203 writers in the first 8 months of 2024.- Data Management and Efficiency: Created an Excel template that enables me to input territory data and organize targets based on provider script volume, location, and number of providers. This tool allows me to consistently reach the providers responsible for 80% or more of the scripts written in the Buffalo territory within a 4-week period, optimizing territory management and increasing sales efficiency.- Budget Management: Developed an Excel budget template for myself and others within the company, allowing precise tracking of the companies yearly budget. This tool ensures that resources are used efficiently and helps prevent budget overruns.- Health Insurance Navigation: Successfully navigate the complex health insurance landscape within New York State and the United States to ensure a smooth transition for providers who begin using Spinosad 0.9%. This expertise facilitated easier adoption and integration of the product into provider practices.- Provider Engagement: Successfully manage multiple lunches and breakfasts each week to educate providers about the benefits of Spinosad 0.9%. Engage with a diverse range of specialties, including Dermatology, Primary Care, Pediatrics, Family Medicine, Urgent Cares, and Hospitals, enhancing product awareness and professional relationships.- Event Planning: Successfully plan dinner events with local community health centers around Western New York (WNY), and assisting with National Conferences fostering stronger relationships and increasing awareness of Spinosad 0.9%.

-Sales Performance: Sold 80 new accounts in one summer, generating $32,000 in revenue, with an average of $2,666 in revenue produced per week. Exceeded sales requirements by 50 sales, achieving 167% of the target in the competitive Door-to-Door Pest Control Market. - Client Interaction: Interacted with over 75 prospective clients daily to grow the business and address unique client needs, demonstrating strong communication skills and customer focus.